Huntington Cancer Center, an Affiliate of CS Cancer

Pasadena, California 91105

1 studies enrolling now · 1 studies all time

What they study most

Early Stage Triple-Negative Breast Carcinoma, TNBC, TNBC - Triple-Negative Breast Cancer

Studies at this site

• Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer — Recruiting now